Denali Therapeutics, Inc. (DNLI)

16.87 -0.12 (-0.71%) USD  |  NASDAQ  |  Dec 26, 16:00
16.86 -0.01 (-0.06%) After-Hours: 20:00
More

Denali Therapeutics Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Masimo Corp. Upgrade
Novavax, Inc. --
Protalix Biotherapeutics, Inc. --
iRhythm Technologies, Inc. --
Twist Bioscience Corp. Upgrade